Clinical Trial Update: Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac [Phase 1]

View source ↗

Summary

Phase 1 clinical trial exploring safe intensification of hypofractionated glioblastoma treatment on an MR-Linac; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Snippet

Sponsor: NYU Langone Health | Conditions: High-grade Glioma | Phase 1 | Status: NOT_YET_RECRUITING